BHIC · XBRL financial data

BioScience Health Innovations financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (BHIC's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jul 1, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25†Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue	192	304*	278	—	573	610*	1,227	1,757	1,131	1,573*	751	1,036
Cost of goods and services sold	32	year only	43	—	148	271*	331	683	433	1,001*	265	377
Gross profit	160	—	235	—	425	339*	896	1,074	698	572*	486	659
Research and development	—	0*	1	—	26*	(4)*	38	9*	20*	95*	50	71*
Selling, general and administrative	210	265*	278	—	345	300*	434	540	577	656*	626	—
General and administrative	—	—	—	—	—	—	—	540	—	—	—	804
Total operating expenses	217	275*	288	—	369	329*	469	617	707	729*	716	877
Operating income (loss)	(57)	(38)*	(53)	—	56	10*	427	458	(9)	(157)*	(230)	(218)
Income tax expense (benefit)	0	0*	—	—	0	0*	—	0	—	year only	—	(32)
Net income (loss)	(57)	(38)*	(53)	—	56	10*	427	458	(9)	(234)*	(230)	(186)
Earnings per share, basic USD per share	0.00	—	0.00	—	0.00	0.00*	0.01	0.01	0.00	—	(0.02)	(0.02)
Earnings per share, diluted USD per share	0.00	—	0.00	—	0.00	0.00*	0.01	0.01	0.00	—	(0.02)	(0.02)
Weighted average shares, basic thousands of shares	40,363	—	41,392	—	42,091	42,648*	43,916	43,916	10,979	—	11,377	11,684
Weighted average shares, diluted thousands of shares	40,363	—	41,392	—	42,091	43,903*	44,336	44,336	10,979	—	11,377	11,684

† Share count changed about 1/4 in the period ending 2025-09-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Fiscal quarters (BHIC's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jul 1, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25†Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	42	19	93	—	333	663	1,028	1,299	1,139	662	1,145	712
Accounts receivable	19	36	21	—	32	100	93	390	63	399	78	397
Inventory	34	38	40	—	42	58	216	249	758	336	874	797
Total current assets	95	93	155	—	409	848	1,339	1,985	1,995	1,559	2,195	1,987
Right-of-use asset	—	—	—	—	—	0	—	—	—	61	48	35
Total assets	95	93	155	—	416	874	1,395	2,057	2,067	1,707	2,330	2,136
Accounts payable	8	8	4	—	8	8	16	17	10	6	7	10
Accrued liabilities	—	1	2	—	3	6	21	25	7	8	23	29
Total liabilities	86	100	40	—	46	39	133	338	356	230	646	301
Retained earnings (accumulated deficit)	(390)	(428)	(481)	—	(351)	(341)	86	543	535	301	71	(115)
Total stockholders' equity	9	(7)	115	—	370	835	1,262	1,720	1,711	1,477	1,684	1,835
Total liabilities and equity	95	93	155	—	416	874	1,395	2,057	2,067	1,707	2,330	2,136
Common shares outstanding (cover page) thousands of shares	40,793	41,596	41,596	42,096	42,096	43,916	43,916	43,916	10,979	11,367	11,416	11,752

† Share count changed about 1/4 in the period ending 2025-09-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Fiscal quarters (BHIC's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jul 1, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25†Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	(57)	(38)*	(53)	—	56	10*	427	458	(9)	(234)*	(230)	(186)
Net cash from operating activities	(70)*	(56)*	(48)	—	52*	(50)*	328	285*	(340)*	(101)*	(552)	(542)*
Net cash from investing activities	0*	0*	0	—	(7)*	(19)*	(30)	(16)*	0*	(11)*	0	(27)*
Proceeds from issuing common stock	120	25*	175	—	125	455*	0	0*	0*	0*	437	336*
Proceeds from issuing equity	120*	—	—	—	—	—	—	—	—	—	—	—
Net cash from financing activities	82*	34*	122	—	144*	399*	68	2*	180*	(366)*	1,035	136*

† Share count changed about 1/4 in the period ending 2025-09-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

SIC 7374 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 7374 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
BioScience Health Innovations	712	1,036	(542)*	11.8M	1.3 quarters	Q2 FY26 10-QJun 30, 2026
Airwa	11,085	21,244	27,672	4.6M	—	Q1 FY26 10-QJul 31, 2026
Marketwise	32,914	75,808	22,421*	not reported	—	Q2 FY26 10-QJun 30, 2026
Dirtt Environmental Solutions	14,826	40,310	941	194.3M	—	Q2 FY26 10-QJun 30, 2026
Nixxy	330	16,091	(982)*	28.9M	1.8 quarters	Q2 FY26 10-QJun 30, 2026
Healthcare Triangle	1,906	9,193	(833)*	15.0M	2.3 quarters	Q2 FY26 10-QJun 30, 2026
Upland Software	31,044	49,141	5,370*	3.0M	—	Q2 FY26 10-QJun 30, 2026
Veea	1,942	176	(5,932)*	62.2M	0.3 quarters	Q2 FY26 10-QJun 30, 2026
SeeQC	18,116	937	not reported	11.1M	—	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.